PMC Group International Announces Acquisition of Pharma Company in France
Tuesday, 05 December 2017
MOUNT LAUREL, NJ (December 4, 2017) — PMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group Inc., announced the acquisition of the pharma business of Isochem SAS of France. This is a fully integrated business comprised of research, product/process development, regulatory approvals, pilot scale
- Published in News
No Comments
PMC Group International Announces Acquisition of Pharma Company in India
Wednesday, 01 November 2017
MOUNT LAUREL, NJ (October 28, 2017) — PMC YM-Pharma Private Ltd., a subsidiary of PMC Group International, an independent arm of PMC Group Inc., announced the acquisition of the assets of Yegna Manojavam Drugs and Chemicals Ltd (YMDCL) of Hyderabad, India. The cGMP manufacturing facility of YMDCL is one of the largest fluoroquinolone drug manufacturers
- Published in News
PMC Organometallix Announces Distribution Agreement With Safic-Alcan In Europe
Monday, 09 October 2017
CARROLLTON, KY (October 01, 2017) – PMC Organometallix, Inc., a wholly owned subsidiary of PMC Group, has expanded its distribution agreement with Safic-Alcan to include Eastern Europe providing customers with sales, order fulfillment, and technical support. Effective immediately, Safic-Alcan will serve as an authorized distributor of PMC Organometallix’ s FASCAT® catalysts and Fine Chemicals—highly selective catalysts
- Published in News
PMC Biogenix Consolidates Product Distribution Channels
Tuesday, 09 May 2017
MEMPHIS, TN (May 9, 2017) – PMC Biogenix, Inc., a wholly owned subsidiary of PMC Group, as part of its continuing effort to strengthen and build upon customer relationships, has initiated a comprehensive review of its go to market strategy. As part of this process, PMC Biogenix is consolidating certain historical product distribution channels in
- Published in News